N 593 2
Pill imprint N 593 2 has been identified as Doxazosin mesylate 2 mg.
Doxazosin is used in the treatment of benign prostatic hyperplasia; high blood pressure; raynaud's syndrome and belongs to the drug class antiadrenergic agents, peripherally acting. Risk cannot be ruled out during pregnancy.
Doxazosin 2 mg is not subject to the Controlled Substances Act.
See also related documents.
Doxazosin mesylate Images
- Imprint:
-
N 593
2 - Strength:
- 2 mg
- Color:
- White
- Size:
- 10.00 mm
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Inactive Ingredients:
- microcrystalline cellulose
lactose monohydrate
sodium starch glycolate type A potato
magnesium stearate
corn starch
sodium lauryl sulfate
- Drug Class:
- Antiadrenergic agents, peripherally acting
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Teva Pharmaceuticals USA
- National Drug Code (NDC):
- 00093-8121
Advertisement
More Doxazosin Mesylate resources
- Doxazosin
- Doxazosin (Wolters Kluwer)
- Doxazosin Extended-Release Tablets (Wolters Kluwer)
- doxazosin (Cerner Multum)
- doxazosin (Micromedex) - Includes Dosage Information
- Doxazosin Mesylate (AHFS DI)
- Doxazosin (FDA)
- Doxazosin Mesylate (Wolters Kluwer)
Search Again
